Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus

European Journal of Pharmacology

Volumn 297, Issue 3, 1996, Pages 219-224

  Kanthasamy, Anumantha G ^a   Vu, Toan Q ^a   Yun, Richard J ^a   Truong, Daniel D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiepileptic; Drug screening; Excitatory amino acid; GABA ( aminobutyric acid); Ischemia; Neurological disorder; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; CHLORPHENOTANE; GABAPENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; HEART ARREST; HYPOXIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MYOCLONUS SEIZURE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030058563     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00741-5     Document Type: Article

References (43)

1. Artieda, J. and J.A. Obeso, 1993, The pathophysiology and pharmacology of photic cortical reflex myoclonus, Ann. Neurol. 34, 175.
2. Bartoszyk, G.D., 1983, Gabapentin and convulsions provoked by excitatory amino acids, Naunyn-Schmied. Arch. Pharmacol. 324 (Suppl.), R24.
3. Bartoszyk, G.D. and M. Hamer, 1987, The genetic animal model of reflex epilepsy in the Mongolian gerbil: differential efficacy of new anticonvulsive drugs and prototype antiepileptics, Pharmacol. Res. Commun. 19, 429.
4. Bartoszyk, G.D., N. Meyerson, W. Reimann, G. Satzinger and A. Von Hodenberg, 1986, New anticonvulsant drugs: gabapentin, in: Current Problems in Epilepsy, Vol. 4, eds. B.S. Meldrum and R.J. Porter (John Libbey, London) p. 147.
5. Browne, T., 1993, Efficacy and safety of gabapentin, in: New Trends in Epilepsy Management: Role of Gabapentin, ed. D. Chadwick (Royal Society of Medicine Services, London) p. 47.
6. Chadwick, D., 1993, Gabapentin, in: Recent Advances in Epilepsy, Vol. 5, eds. T.A. Pedley and B.S. Meldrum (Churchill Livingstone, London) p. 211.
7. Chapman, A.G., J.L. Graham, S. Patel and B.S. Meidrum, 1991, Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in papio papio, Epilepsia 32, 578.
8. Cordero, M.L., J.G. Ortiz, G. Santiago, A. Negron and J.A. Moreira, 1994, Altered GABAergic and glutamic transmission in audiogenic seizure susceptible mice, Mol. Neurobiol. 9, 253.
9. Deahl, M. and M. Trimble, 1991, Serotonin reuptake inhibitors, epilepsy and myoclonus, Br. J. Psychol. 159, 433.
10. De Lean, J., J.C. Richardson and O. Hornykiewicz, 1976, Beneficial effects of serotonin precursors in postanoxic action myoclonus, Neurology 26, 863.
11. Fahn, S., 1986, Posthypoxic action myoclonus: literature review and update, Adv. Neurol. 26, 49.
12. Faingold, C.L., M.J. Marcinczyk, D.J. Casebeer, M.E. Randall, S.P. Arneric and R.A. Browning, 1994, GABA in the inferior colliculus plays a critical role in control of audiogenic seizures, Brain Res. 640, 40.
13. Goa, K.L. and E.M. Sorkin, 1993, Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy, Drugs 46, 409.
14. 3H]gabapentin to a novel site in rat brain: autoradiographic studies, Eur. J. Pharmacol. 244, 303.
15. Hooper, W.D., M.C. Kavanagh, G.K. Herkes and M.J. Eadie, 1991, Lack of a pharmacokinetic interaction between phenobarbitone and gabapentin, Br. J. Clin. Pharmacol. 31, 171.
16. Honmou, O., J.D. Kocsis and G.B. Richerson, 1995, Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro, Epilepsy Res. 20, 193.
17. Hwang, E.-C. and M.H. Van Woert, 1978, p,p′-DDT-induced neurotoxic syndrome: experimental myoclonus, Neurology 28, 1020.
18. Jobe, P.C., P.K. Mishra and J.W. Dailey, 1992, Genetically epilepsy-prone rats: actions of antiepileptic drugs and monoaminergic neurotransmitters, in: Drugs for Control of Epilepsy. Actions on Neuronal Networks Involved in Seizure Disorders, eds: C.L. Faingold and G.H. Fromm (CRC Press, Boca Raton, FL) p. 253.
19. Kawai, K., L. Nitecka, C.A. Ruetzler, G. Nagashima, F. Joo, G. Mies, T.S. Nowak, N. Saito, J.M. Lohr and I. Klatzo, 1992, Global cerebral ischemia associated with cardiac arrest in rat. I. Dynamics of early neuronal changes, J. Cereb. Blood Flow Metab. 12, 238.
20. Kawai, K., L.P. Penix, N. Kawahara, C.A. Ruetzher and I. Klatzo, 1995, Development of susceptibility to audiogenic seizures following cardiac arrest cerebral ischemia in rats, J. Cereb. Blood Flow Metab. 15, 248.
21. Kocsis, J.D. and O. Honmou, 1994, Gabapentin increases GABA-induced depolarization in rat neonatal optic nerve, Neurosci. Lett. 169, 181.
22. Krumholz, A., B.J. Stern and H.D. Weiss, 1988, Outcome from coma after cardiopulmonary resusciation: relation to seizures and myoclonus, Neurology 38, 401.
23. Löscher, W., D. Honack and C.P. Taylor, 1991, Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain, Neurosci. Lett. 128, 150.
24. Matsumoto, R.R., D.C. Nguyen and D.D. Truong, 1995a, Strychnine-insensitive glycine site antagonists attenuate a cardiac arrest-induced movement disorder, Eur. J. Pharmacol. 275, 117.
25. Matsumoto, R.R., N. Aziz and D.D. Truong, 1995b, Association between brain indole levels and severity of posthypoxic myoclonus in rats, Pharmacol. Biochem. Behav. 50, 533.
26. Mervaala, E., F. Andermann, L.F. Quesnay and M. Krelina, 1990, Common dopaminergic mechanism for epileptic photosensitivity in progressive myoclonus epilepsies, Neurology 40, 53.
27. A receptor is involved in the pathogenesis of myoclonus, Neurology, 45 (Suppl. 4), A187.
28. Patel, S. and P. Slater, 1987, Analysis of the brain regions involved in myoclonus produced by intracerebral picrotoxin, Neuroscience 20, 687.
29. Pranzatelli, M.R., P.T. Tailor, R. Pluchino, W. Gonzales and S. Simmens, 1994, p,p′-DDT myoclonic/epileptic model: serotonin receptor binding and behavioral studies in the rat, Neurotoxicology 15, 261.
30. Ramsay, E.R., 1994, Clinical efficacy and safety of gabapentin, Neurology 44 (Suppl. 5), S23.
31. Rock, D.M., K.M. Kelly and R.L. MacDonald, 1993, Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons, Epilepsy Res. 16, 89.
32. Shuaib, A., S. Ijaz, H. Miyashita, T. Mainprize and R. Kanthan, 1994, Progressive decrease in extracellular GABA concentrations in the postischemic period in the striatum: a microdialysis study, Brain Res. 666, 99.
33. Sivenius, J., R. Kalviainen, A. Ylinen and P. Riekkinen, 1991, Double-blind study of gabapentin in the treatment of partial seizures, Epilepsia 32, 539.
34. Snodgrass, S.R., 1990, Myoclonus: analysis of monoamine, GABA and other systems, FASEB J. 4, 2775.
35. Taylor, C.P., 1993, Mechanism of action of new anti-epileptic drugs, in: New Trends in Epilepsy Management: The Role of Gabapentin, ed. D. Chadwick (Royal Society of Medicine Services, New York) p. 13.
36. Taylor, C.P., 1994, Emerging perspectives on the mechanism of action of gabapentin, Neurology 44 (Suppl. 5), S10.
37. Taylor, C.P., M.G. Vartanian and R. Andruszkiewicz, 1992, 3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents, Epilepsy Res. 11, 103.
38. Truong, D.D., M.P. Galloway, G. Pennoli, Z. Jamrozik and S. Fahn, 1989, Milacemide increases 5-hydroxytryptamine and dopamine levels in rat brain - possible mechanisms of milacemide antimyoclonic property in the p,p′-DDT-induced myoclonus, Pharmacol. Biochem. Behav. 32, 993.
39. Truong, D.D., R.R. Matsumoto, P.H. Schwartz, M.J. Hussong and C.G. Wasterlain, 1994, A novel rat cardiac arrest model of posthypoxic myoclonus, Mov. Disord. 9, 201.
40. US Gabapentin Study Group No. 5., Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study, Neurology 43, 2292.
41. Van Woert, M.H., D. Rosenbaum and E. Chung, 1986, Biochemistry and therapeutics of posthypoxic myoclonus, Adv. Neurol. 43, 171.
42. Welty, D., G.P. Schielke, M.G. Vartanian and C.P. Taylor, 1993, Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate, Epilepsy Res. 16, 175.
43. Wijdicks, E.F.M., J.E. Parisi and F.W. Sharbrough, 1994, Prognostic value of myoclonus status in comatose survivors of cardiac arrest, Ann. Neurol. 35, 239.